Abstract
The use of catheter-directed, endovascular mechanical thrombolysis has revolutionized the treatment of acute ischemic strokes in the last few years. Acute ischemic stroke remains the third most common cause of death and the first most common cause of permanent adult disability in industrialized nations. Each year, approximately 795,000 people experience a new or recurrent stroke in the USA, with its direct and indirect annual cost estimated as more than $40 billion. The only Food and Drug Administration (FDA)-approved medical therapy for acute ischemic stroke is the intravenous (IV) administration of recombinant tissue-type plasminogen activator (rtPA) within 3 h of symptom onset. The European Cooperative Acute Stroke Study (ECASS) III trial expanded the utilization of IV rtPA up to 4.5 h from symptom onset, albeit with more contraindications. Given this restricted therapeutic window, less than 1 % of acute ischemic stroke patients receive IV rtPA. Moreover, the recanalization rates of IV rtPA for proximal, large vessel occlusions range from only 10 % for internal carotid artery (ICA) occlusions to 30 % for middle cerebral artery (MCA) occlusions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ACT:
-
Activated coagulation time
- AIS:
-
Acute ischemic stroke
- AP:
-
Anteroposterior
- CT:
-
Computed tomographic
- ECASS:
-
European Cooperative Acute Stroke Study
- FDA:
-
Food and Drug Administration
- F:
-
French
- ICA:
-
Internal carotid artery
- IMS:
-
Interventional Management of Stroke
- IV:
-
Intravenous
- MCA:
-
Middle cerebral artery
- MERCI:
-
Mechanical Embolus Removal in Cerebral Ischemia
- mRS:
-
Modified Rankin Scale
- NIHSS:
-
National Institutes of Health Stroke Scale
- POST:
-
Post-market experience of the Penumbra system trial
- PTT:
-
Partial thromboplastin time
- rtPA:
-
Recombinant tissue-type plasminogen activator
- SARIS:
-
Stent-Assisted Recanalization in acute ischemic Stroke
- TIMI:
-
Thrombolysis in Myocardial Infarction
References
Report of the WHO Task Force on Stroke and other CerebrovasÂcular Disorders. Stroke – 1989. Recommendations on stroke Âprevention, diagnosis, and therapy. Stroke. 1989;20:1407–31.
Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics – 2012 update: a report from the American Heart Association. Circulation. 2012;125:e2–220.
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–7.
Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317–29.
Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology. 2001;56:1015–20.
Wolpert SM, Bruckmann H, Greenlee R, Wechsler L, Pessin MS, del Zoppo GJ. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. AJNR Am J Neuroradiol. 1993;14:3–13.
del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke. 1998;29:4–11.
Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282:2003–11.
Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke. 2005;36:1432–8.
Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke. 2008;39:1205–12.
IMS Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke. 2004;35:904–11.
IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II Study. Stroke. 2007;38:2127–35.
Tomsick T, Broderick J, Carrozella J, Khatri P, Hill M, Palesch Y, et al. Revascularization results in the Interventional Management of Stroke II trial. AJNR Am J Neuroradiol. 2008;29:582–7.
Brott T, Adams Jr HP, Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864–70.
TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. N Engl J Med. 1985;312:932–6.
Zaidat OO, Wolfe T, Hussain SI, Lynch JR, Gupta R, Delap J, et al. Interventional acute ischemic stroke therapy with intracranial self-expanding stent. Stroke. 2008;39:2392–5.
Levy EI, Siddiqui AH, Crumlish A, Snyder KV, Hauck EF, Fiorella DJ, et al. First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke). Stroke. 2009;40:3552–6.
Gralla J, Schroth G, Remonda L, Nedeltchev K, Slotboom J, Brekenfeld C. Mechanical thrombectomy for acute ischemic stroke: thrombus-device interaction, efficiency, and complications in vivo. Stroke. 2006;37:3019–24.
Tarr R, Hsu D, Kulcsar Z, Bonvin C, Rufenacht D, Alfke K, et al. The POST trial: initial post-market experience of the Penumbra system: revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe. J Neurointerv Surg. 2010;2:341–4.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Eller, J.L., Hopkins, L.N., Levy, E.I. (2014). Intracranial Strokes: Mechanical Thrombectomy Using the Merci and Penumbra Devices. In: Dieter, R., Dieter, Jr., R., Dieter, III, R. (eds) Endovascular Interventions. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7312-1_1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7312-1_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7311-4
Online ISBN: 978-1-4614-7312-1
eBook Packages: MedicineMedicine (R0)